Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Ginsenoside compound K shows promise for treating metabolic diseases like diabetes and obesity.

New drugs like clonidine and prazosin show promise for treating high blood pressure despite some side effects.

Minoxidil analogs can be improved for hair growth inhibition by modifying specific parts of their structure.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Tadalafil is effective for treating urinary symptoms in men with BPH.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Scientists found new nonsteroidal compounds that can act like natural male hormones and might help treat male fertility and hormone issues.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Intravenous and oral calcium effectively treated vitamin D dependent rickets type II, improving growth and bone health.

Certain inhibitors applied to the skin can promote hair growth by maintaining a key hair growth signal.

Trilostane effectively improved symptoms in dogs with a certain adrenal gland disorder.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

Thyroid-stimulating hormone affects hair follicles but doesn't change hair growth or color.

GSK-36 downregulation with UTMD improves plaque stability in atherosclerosis treatment.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

PDE3 inhibitor may help treat hair loss by promoting hair growth.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

A new compound shows promise as a topical treatment for hair loss.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.